Cell and Gene Therapy Products

Articles containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer to a human recipient. Gene therapies are novel and complex products that can offer unique challenges in product development. Hence, ongoing communication between the FDA and stakeholders is essential to meet these challenges. Gene therapy products are being developed around the world, the FDA is engaged in a number of international harmonization activities in this area.

Examples: Musculoskeletal tissue, skin, ocular tissue, human heart valves; vascular graft, dura mater, reproductive tissue/cells, Stem/progenitor cells ,somatic cells, Cells transduced with gene therapy vectors , Combination products (e.g., cells or tissue + device)

Related conferences: International Conference on Clinical And Molecular Genetics, 28-30 November 2016 (Chicago, USA); 6th International Conference on Genomics & Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress on Human Genetics, 31October – 02November 2016 (Valencia, Spain); International Conference on Genetic Counselling And Genomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell & Gene Therapy Congress, 19-21 May 2016 ( San Antonio, USA); 2015 Midwest Conference on Cell Therapy & Regenerative Medicine September 18-19 2015 (Kansas City, Missouri); 2nd Cell & Gene Therapy Conference 9-10 September 2015 (Philadelphia, United States); Cell & Gene Therapy Europe 29-30 September 2015 (Barcelona, Spain); Cell Manufacturing and  Gene Therapy Congress 2015 2-3 December 2015 (Brussels, Belgium). 

Gene therapy products often initially appear promising because they reflect strong scientific rationale when they are proposed as treatments for specific, well-defined genetic disorders. In addition, some gene therapy products have been well publicized because they offer hope for the treatment of rare, disabling, or life-threatening disorders. Despite strong scientific rationale and publicity-generated enthusiasm, the field has not yet produced any products that have gone through clinical development and provided the evidence of safety and effectiveness. ommercial-scale manufacturing of cell-based therapies requires substantial infrastructure – a manufacturing facility setup for controlled production, skilled staff with expertise including cell therapy-specific manufacturing strategies, technology, and regulatory requirements.

  • Cellular immuno therapy products
  • Cellular & gene therapy products
  • Allogeneic & autologous therapy products
  • Cell based therapy products
  • Tissue based products

Related Conference of Cell and Gene Therapy Products

September 3-4, 2018

World Congress on Stem Cell Biology and Biobanking

Tokyo, Japan
September 19 - 20, 2018

2nd Annual summit on Cell Signaling and Cancer Therapy

Philadelphia, Pennsylvania, USA
September 19 - 20, 2018

2nd Annual summit on Cell Metabolism and Cytopathology

Philadelphia, Pennsylvania, USA
September 21-22, 2018

11th International Conference on Genomics and Pharmacogenomics

Philadelphia, Pennsylvania, USA
September 21-22, 2018

5th International Conference on Human Genetics and Genetic Diseases

Philadelphia, Pennsylvania, USA
October 08-09, 2018

10th Annual Conference on Stem Cell and Regenerative Medicine

Zurich, Switzerland
October 11-12, 2018

21st European Biotechnology Congress

Holiday Inn Vinogradovo, Moscow, Russia
October 17-18, 2018

Annual Congress on Cellular Therapies, Cancer, Stem Cells and Bio Medical Engineering

Hilton New York JFK Airport Hotel, Address: 144-02 135th Avenue, Jamaica, New York 11436 , USA
October 18-20, 2018

11th International Conference on Tissue Engineering & Regenerative Medicine

Hotel: Holiday Inn Rome Aurelia, Rome, Italy
October 24-25, 2018

24th Biotechnology Congress: Research & Innovations

Crowne Plaza Newton Hotel, Boston, Massachusetts, USA
October 24-25, 2018

Annual congress on CRISPR-Cas9 Technology and Genetic Engineering

Crowne Plaza Newton Hotel, Boston, Massachusetts, USA
November 9-10, 2018

2nd Annual Summit on Stem Cell Research, Cell and Gene Therapy

Atlanta, Georgia, USA
November 15-16, 2018

5th World Congress on Epigenetics and Chromosome

Istanbul, Turkey
November 19-20, 2018

22nd World Congress on Biotechnology

Bangkok, Thailand
November 26-27, 2018

International Epigenetics and Epitranscriptomics Conference

Helsinki,Finland
November 27-28, 2018

8th International Conference on Cell & Gene Therapy

Athens, Greece
Dec 03-04, 2018

3rd World Biotechnology Congress


(10 Plenary Forums - 1Event)
Sao Paulo, Brazil
March 11-12, 2019

12th World Congress on Cell & Tissue Science

Singapore
March 20-21, 2019

2nd World Congress on Cell and Structural Biology

Sydney, Australia
March 25-26, 2019

11th World Congress and Expo on Cell & Stem Cell Research

Orlando, Florida, USA
April 11-12, 2019

9th World Congress on Plant Genomics and Plant Sciences

Wellington, Newzealand
April 15-16, 2019

7th International Conference on Integrative Biology

Berlin, Germany
April 22-23, 2019

International Conference on Cord Blood Banking

Vancouver, British Columbia, Canada
June 10-12, 2019

10 th Tissue Repair and Regeneration Congress

Helsinki, Finland
July 29-30, 2019

2nd Annual Biotechnology Congress

Chicago, USA

Cell and Gene Therapy Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in